All In Biotech

Free tool

FAERS Monitor: Diovan Hct

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020818 or its brand name (Diovan Hct, Hydrochlorothiazide, Valsartan). Reports on generic versions are filed under their own applications.

Reports

13,539

Serious

10,407

77% of reports

Hospitalization

4,212

Death reported

1,385

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood pressure increased822
  • dizziness803
  • hypertension780
  • drug ineffective748
  • headache712
  • fatigue691
  • nausea656
  • dyspnoea614
  • malaise570
  • fall561
  • pain532
  • death501
  • diarrhoea466
  • cerebrovascular accident446
  • asthenia429

Reports by year received

View as table
YearReports
2004186
2005309
2006343
2007597
2008777
20091,278
20101,089
20111,310
20121,447
2013793
2014647
2015732
2016757
2017521
2018667
2019468
2020394
2021288
2022232
2023222
2024167
2025181
2026134

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,620 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure increasedSignal8228.47.95,355
hypertensionSignal7805.75.43,067
cerebrovascular accidentSignal4464.13.71,047
fallSignal5612.62.4569
dizzinessSignal8032.52.3740
malaiseSignal5702.01.9299
asthenia4291.81.6146
headache7121.81.6242
dyspnoea6141.71.6175
fatigue6911.41.374
pain5321.31.248
nausea6561.31.244
diarrhoea4661.11.06
death5010.90.85
drug ineffective7480.90.813

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.